Top-Rank Health Care Co., Ltd. is identified in FDA records as the applicant for a Traditional 510(k), K260575, covering the device trade-named AutoGel Pad (400-046, 400-005). The filing carries product code MUI, regulation 21 CFR 892.1570, Class II, and a Radiology advisory committee assignment, with a decision of Substantially Equivalent dated October 30, 2026. The same applicant name appears on an earlier clearance letter, K222770, for a device trade-named Conductive Gel under 21 CFR 882.1275, product code GYB, Class II. [1][6][8]

The AutoGel Pad filing and its scope

K260575 was received February 20, 2026, and decided October 30, 2026, as a Traditional clearance with no third-party review. The FDA record lists the device as AutoGel Pad (400-046, 400-005), product code MUI, device class 2, regulation 892.1570, with the classification name Media, Coupling, Ultrasound and medical specialty Radiology. The submission included a Summary rather than a Statement. [1][8]

The clearance letter for K260575 restates the trade/device name and identifies 21 CFR 892.1570 as Diagnostic Ultrasonic Transducer, Class II, product code MUI, with dates of September 30, 2026 shown for the letter's dated and received fields. The FDA database entry for the same number points to a publicly posted decision PDF. [9][2]

An earlier Conductive Gel clearance

The December 13, 2022 clearance letter for K222770 names Top-Rank Health Care Co., Ltd. as the applicant through a correspondent, with the trade/device name Conductive Gel, regulation 21 CFR 882.1275 (Electroconductive media), Class II, product code GYB. The accompanying 510(k) summary identifies the sponsor as Top-Rank Health Care Co. Ltd. at a Mashan Village, Dongguan Street, Shangyu District, Shaoxing City, Zhejiang Province address and lists a chairman as contact. [6]

That summary was prepared December 8, 2022, and the letter is dated December 13, 2022. The FDA premarket notification database page for K222770 is a separate public index entry for the same submission number. [6][7]

How the company describes its manufacturing

On its own product page, Top-Rank describes AutoGel Pads as pre-formed, solid-phase acoustic standoff hydrogel pads intended for high-resolution diagnostic ultrasound examinations, and states that synthesis and automated casting occur in ISO 13485-certified Class 8 cleanrooms under US FDA 21 CFR 820 design controls. The same page lists a baseline private-label contract manufacturing minimum order quantity of 10,000 units and presents the item as an OEM, FDA 510(k)-cleared ultrasound gel. These are company-published claims, not FDA findings. [3]

The company's homepage describes Top-Rank Healthcare as an OEM/ODM manufacturer certified under MDSAP, ISO 13485 and ISO 14001, holding FDA, CE and UKCA registrations, and lists TENS electrodes, grounding pads and conductive gels among its outputs. It also describes vertical integration from raw hydrogel synthesis to finished electrodes. These statements originate with the company. [4]

What the supplied filings show

The supplied collection contains one linked 510(k) record, K260575, with a decision count of one Substantially Equivalent entry; the explicitly smaller record sample contains the same single row. These figures describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the public information. [1]

A company news item dated November 4, 2026, discusses what B2B buyers should know about FDA 510(k)-cleared ultrasound gel pads and refers to specifications such as acoustic impedance, sound velocity, attenuation, dimensions, material properties, packaging and storage, noting that required specifications depend on the intended application. It does not report test results. [5]